Sean Kennedy

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours

Michael Warso, Jon Richards, Divya Mehta et al. · British Journal of Cancer · 2013 · 182 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors

Elisabeth I. Heath, Séamus O’Reilly, Rachel Humphrey et al. · Cancer Chemotherapy and Pharmacology · 2001 · 55 citations

Medicine, Oncology, Pharmacology +9

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer

Cha Len Lee, Mattia Cremona, Angela M. Farrelly et al. · Cancer Biology & Therapy · 2023 · 25 citations · Full text

Medicine, Oncology, Pharmacology +14